NEW YORK, NY, Stratum Biosciences, a biotechnology pioneer at the intersection of artificial intelligence and dermatology research, announced the closing of a $2M seed funding.
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.